3-(3,5-Dibromo-4-hydroxyphenyl)-N-(4-phenoxybenzyl)-1,2,4-oxadiazole-5-carboxamide

CAS: 1191252-49-9

Ref. 3D-RXB25249

Produktinformation

• Name: 3-(3,5-Dibromo-4-hydroxyphenyl)-N-(4-phenoxybenzyl)-1,2,4-oxadiazole-5-carboxamide

Beschreibung

3-(3,5-Dibromo-4-hydroxyphenyl)-N-(4-phenoxybenzyl)-1,2,4-oxadiazole-5-carboxamide is a quinazoline derivative that inhibits the voltage gated sodium channels. 3-(3,5-Dibromo-4-hydroxyphenyl)-N-(4-phenoxybenzyl)-1,2,4-oxadiazole-5-carboxamide has been shown to be a potent inhibitor of the polycystic kidney disease (PKD) in rats. It also has anti-cancer effects and can inhibit the growth of human cancer cells. This compound was originally developed as an analgesic.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 545.19 g/mol
• Formel: C₂₂H₁₅Br₂N₃O₄
• Reinheit: Min. 95%